Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.01; Reports Implementation of Austerity Measures
Go back to Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.01; Reports Implementation of Austerity Measures| HEMISPHERX BIOPHARMA, Inc. (NYSE: HEB) | Delayed: 1.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $1.48 | |||
| Open | $1.46 | 52 Week Low | $0.06 | |||
| Day High | $1.80 | P/E | N/A | |||
| Day Low | $1.80 | EPS | $-0.11 | |||
| Volume | 94,971 | |||||
